Second Booster BNT162b2 Restores SARS-CoV-2 Humoral Response in Patients With Multiple Myeloma, Excluding Those Under Anti-BCMA TherapyIoannis Ntanasis‐Stathopoulos, Evangelos Terpos, Μαρία Ρούσσου et al.|HemaSphere|2022Cited by 44